Oct 24 (Reuters) – BAYER AG: * PHASE III DASL-HICAP TRIAL MET PRIMARY ENDPOINT OF METASTASIS-FREE SURVIVAL * DAROLUTAMIDE PLUS ADT AND RADIATION THERAPY REDUCED RISK OF METASTASIS OR DEATH BY 58% IN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 24 (OPTA) - Scores from the European Tour-Genesis Championship 2026 Genesis Championship on Friday…
Oct 24 (OPTA) - Scores from the LPGA Tour-BMW Ladies Championship 2026 BMW Ladies Championship…
Jalen Johnson and reserve Aaron Wiggins each scored 19 points as visiting Atlanta blew out…
Oct 24 (Reuters) - * TOYOTA MOTOR ENGINEERING & MANUFACTURING IS RECALLING 68,356 U.S. VEHICLES…
CHINA'S PREMIER LI QIANG WENT TO DANDONG TO MEET NORTH KOREA'S KIM JONG UN -YONHAP…
* Bridge opened this month in latest sign of warming Beijing-Pyongyang ties * Kim last…